153 related articles for article (PubMed ID: 20211659)
1. Granins and granin-related peptides in neuroendocrine tumours.
Portela-Gomes GM; Grimelius L; Wilander E; Stridsberg M
Regul Pept; 2010 Nov; 165(1):12-20. PubMed ID: 20211659
[TBL] [Abstract][Full Text] [Related]
2. Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II.
Portela-Gomes GM; Grimelius L; Stridsberg M
Regul Pept; 2010 Nov; 165(1):30-5. PubMed ID: 20550951
[TBL] [Abstract][Full Text] [Related]
3. Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors.
Conlon JM
Regul Pept; 2010 Nov; 165(1):5-11. PubMed ID: 19931574
[TBL] [Abstract][Full Text] [Related]
4. Chromogranins A and B and secretogranin II as prohormones for regulatory peptides from the diffuse neuroendocrine system.
Helle KB
Results Probl Cell Differ; 2010; 50():21-44. PubMed ID: 20217490
[TBL] [Abstract][Full Text] [Related]
5. Aspects of the neuroendocrine cerebellum: expression of secretogranin II, chromogranin A and chromogranin B in mouse cerebellar unipolar brush cells.
Nunzi MG; Mugnaini E
Neuroscience; 2009 Sep; 162(3):673-87. PubMed ID: 19217926
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of secretogranin II in 62 neuroendocrine tumours of the digestive tract and of the pancreas in comparison with other granins.
Le Gall F; Vallet VS; Thomas D; De Monti M; Duval J; Ramee MP
Pathol Res Pract; 1997; 193(3):179-85. PubMed ID: 9198103
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors.
Portela-Gomes GM; Grimelius L; Stridsberg M
Cell Mol Neurobiol; 2010 Nov; 30(8):1147-53. PubMed ID: 21046454
[TBL] [Abstract][Full Text] [Related]
8. Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours.
Stridsberg M; Eriksson B; Janson ET
Regul Pept; 2008 Jun; 148(1-3):95-8. PubMed ID: 18448176
[TBL] [Abstract][Full Text] [Related]
9. The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.
Feldman SA; Eiden LE
Endocr Pathol; 2003; 14(1):3-23. PubMed ID: 12746559
[TBL] [Abstract][Full Text] [Related]
10. Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma.
Guérin M; Guillemot J; Thouënnon E; Pierre A; El-Yamani FZ; Montero-Hadjadje M; Dubessy C; Magoul R; Lihrmann I; Anouar Y; Yon L
Regul Pept; 2010 Nov; 165(1):21-9. PubMed ID: 20600356
[TBL] [Abstract][Full Text] [Related]
11. Chromogranin A.
Hendy GN; Bevan S; Mattei MG; Mouland AJ
Clin Invest Med; 1995 Feb; 18(1):47-65. PubMed ID: 7768066
[TBL] [Abstract][Full Text] [Related]
12. The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours.
Ferrari L; Seregni E; Bajetta E; Martinetti A; Bombardieri E
Anticancer Res; 1999; 19(4C):3415-27. PubMed ID: 10629629
[TBL] [Abstract][Full Text] [Related]
13. New insights into granin-derived peptides: evolution and endocrine roles.
Zhao E; Zhang D; Basak A; Trudeau VL
Gen Comp Endocrinol; 2009; 164(2-3):161-74. PubMed ID: 19523383
[TBL] [Abstract][Full Text] [Related]
14. Chromogranins A and B and secretogranin II: evolutionary and functional aspects.
Montero-Hadjadje M; Vaingankar S; Elias S; Tostivint H; Mahata SK; Anouar Y
Acta Physiol (Oxf); 2008 Feb; 192(2):309-24. PubMed ID: 18005393
[TBL] [Abstract][Full Text] [Related]
15. Regulatory peptides from chromogranin A and secretogranin II: putative modulators of cells and tissues involved in inflammatory conditions.
Helle KB
Regul Pept; 2010 Nov; 165(1):45-51. PubMed ID: 19800929
[TBL] [Abstract][Full Text] [Related]
16. Granin-derived peptides.
Troger J; Theurl M; Kirchmair R; Pasqua T; Tota B; Angelone T; Cerra MC; Nowosielski Y; Mätzler R; Troger J; Gayen JR; Trudeau V; Corti A; Helle KB
Prog Neurobiol; 2017 Jul; 154():37-61. PubMed ID: 28442394
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.
Fahrenkamp AG; Wibbeke C; Winde G; Ofner D; Böcker W; Fischer-Colbrie R; Schmid KW
Virchows Arch; 1995; 426(4):361-7. PubMed ID: 7599788
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen.
Lloyd RV; Hawkins K; Jin L; Kulig E; Fields K
Lab Invest; 1992 Sep; 67(3):394-404. PubMed ID: 1405495
[TBL] [Abstract][Full Text] [Related]
19. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies.
Portela-Gomes GM; Stridsberg M; Grimelius L; Falkmer UG; Falkmer S
APMIS; 2004 Oct; 112(10):663-73. PubMed ID: 15601318
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
